Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Midora Steam Oven’s Revolutionary Steam Technology by Hafele Business
  • Appinop Is Revolutionizing The Cryptoexchange Industry By Bringing New Technology To The Turf Business
  • Accessibility, Public-Private Partnership, and Digitalization are keys to anemia eradication: Experts Press Release
  • GenWorks Health Organizes “Hrudhaya Siri” In Collaboration with Srinivas Hospital, Mukka, Mangalore Business
  • Special Campaign 5.0: 7 Ways Sports Department Transforms India’s Administrative Excellence Sports
  • Akanksha Power and Infra IPO opens on 27th December Business
  • ‘Shatak’ Brings to Life the Inspiring Journey of Dr. Hedgewar ji: RSS Chief Mohan Bhagwat ji Entertainment
  • IBC – 2022-23 Continuum Alt Hack builds on the Web3.0 Industry-Academia partnership at Tech Mahindra, Hyderabad Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • National Digital Health Mission approves Verraton Health’s Hospital Information Management System English
  • QSG Kit by Dr. Agravat: The Trailblazing Solution Helping People Quit Gutkha and Smoking across the Nation Health
  • Celebrating Innovation and Hope: Expert’s Insights on World IVF Day Health
  • Respiratory disease burden highest in India, COPD one of the fastest growing respiratory diseases: SMSRC Health
  • South Gujarat’s 1st Arthroscopy & Sports Injury Centre, Launched by Shalby Multispecialty Hospitals Surat Health
  • Narayana Health’s Ground breaking Docu-Series “InsidER” Surpasses 100 Million Streams Health

Recent Posts

  • Zindagi ke Rang, Kissht ke Sang: How Culture and Community Come Together at Kissht
  • Laser Technologies Earns Great Place To Work Certification for 2026
  • A Holi of Harmony, Seva and Devotion: Bhajan Jamming and Birthday Celebration of Shri Radhe Maa
  • Steel Exchange India Ltd (SEIL) to Raise INR 350 Cr via Preferential Issue; IMR Group to Invest 300 Cr in the Company
  • Indcap Advisors Becomes A Founding Member of Advisiom Global M and A

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Growth Expo 2025 Set to Propel India’s Franchise Industry Forward Business
  • T20 World Cup 2026 Super Eight Match Officials Announced Sports
  • Experiential Learning in Action: Wet Port Visit at JNPT, Mumbai Education
  • Kohinoor Eden is the fastest project of Kalyan: 23-Storey RCC Completed in 8 Months using Malaysian Technology Business
  • Best Self Drive Car Rental Company in Jaipur: Your Complete Guide Lifestyle
  • India-UK Free Trade Pact Signed | Transformative Gains on Global Scale National
  • OKR International Announces The 2022 OKRs State of The Industry Report (SOIR) Business
  • Gintaa’s Gig Army: Creating Livelihoods with Dignity Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme